These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11506775)

  • 41. [Bacterial etiology of nosocomial pneumonia and antimicrobial resistance in patients with and without antimicrobial treatment].
    Weyland B; Perazzi B; García S; Rodríguez C; Vay C; Famiglietti A
    Rev Argent Microbiol; 2011; 43(1):18-23. PubMed ID: 21491061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Joseph J; Rodvold KA
    Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin.
    Torres A; Bauer TT; León-Gil C; Castillo F; Alvarez-Lerma F; Martínez-Pellús A; Leal-Noval SR; Nadal P; Palomar M; Blanquer J; Ros F
    Thorax; 2000 Dec; 55(12):1033-9. PubMed ID: 11083889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia.
    Timsit JF; Cheval C; Gachot B; Bruneel F; Wolff M; Carlet J; Regnier B
    Intensive Care Med; 2001 Apr; 27(4):640-7. PubMed ID: 11398689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study.
    Frippiat F; Musuamba FT; Seidel L; Albert A; Denooz R; Charlier C; Van Bambeke F; Wallemacq P; Descy J; Lambermont B; Layios N; Damas P; Moutschen M
    J Antimicrob Chemother; 2015 Jan; 70(1):207-16. PubMed ID: 25216821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of mechanical ventilation & development of multidrug resistant organisms in hospital acquired pneumonia.
    Mukhopadhyay C; Bhargava A; Ayyagari A
    Indian J Med Res; 2003 Dec; 118():229-35. PubMed ID: 14870795
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.
    Yakovlev SV; Stratchounski LS; Woods GL; Adeyi B; McCarroll KA; Ginanni JA; Friedland IR; Wood CA; DiNubile MJ
    Eur J Clin Microbiol Infect Dis; 2006 Oct; 25(10):633-41. PubMed ID: 17024505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of the combination of levofloxacin plus ceftazidime in the treatment of hospital-acquired pneumonia in the intensive care unit.
    Bassetti M; Righi E; Rosso R; Mannelli S; Di Biagio A; Fasce R; Pallavicini FB; Marchetti F; Viscoli C
    Int J Antimicrob Agents; 2006 Dec; 28(6):582-5. PubMed ID: 16979877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Respiratory nosocomial infections in the medical intensive care unit.
    Cavalcanti M; Valencia M; Torres A
    Microbes Infect; 2005 Feb; 7(2):292-301. PubMed ID: 15733530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors for nosocomial pneumonia in critically ill trauma patients.
    Tejada Artigas A; Bello Dronda S; Chacón Vallés E; Muñoz Marco J; Villuendas Usón MC; Figueras P; Suarez FJ; Hernández A
    Crit Care Med; 2001 Feb; 29(2):304-9. PubMed ID: 11246310
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Meropenem in neonatal severe infections due to multiresistant gram-negative bacteria.
    Köksal N; Hacimustafaoğlu M; Bağci S; Celebi S
    Indian J Pediatr; 2001 Jan; 68(1):15-9. PubMed ID: 11237230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ventilator-associated pneumonias in a cardiothoracic surgery centre postoperative intensive care unit.
    Simşek S; Yurtseven N; Gerçekogalu H; Izgi F; Sohtorik U; Canik S; Ozler A
    J Hosp Infect; 2001 Apr; 47(4):321-4. PubMed ID: 11289777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia.
    Pea F; Di Qual E; Cusenza A; Brollo L; Baldassarre M; Furlanut M
    Clin Pharmacokinet; 2003; 42(6):589-98. PubMed ID: 12793843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Adult hospital acquired pneumonia: a multicenter study on microbiology and clinical characteristics of patients from 9 Chinese cities].
    Liu YN; Cao B; Wang H; Chen LA; She DY; Zhao TM; Liang ZX; Sun TY; Li YM; Tong ZH; Wang Z; He B; Yang W; Qu JM; Li XY; Chen RC; Ye F; Kang J; Li ER; Chen P; Zheng Y; Ma ZS; Ren J; Shi Y; Sun WK; Feng YL; Fan H; Jiang SJ; Zhang S; Xiong SD; Zuo P; Wang ZW
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Oct; 35(10):739-46. PubMed ID: 23289990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is ventilator-associated pneumonia in trauma patients an epiphenomenon or a cause of death?
    Magnotti LJ; Croce MA; Fabian TC
    Surg Infect (Larchmt); 2004; 5(3):237-42. PubMed ID: 15684794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME
    Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical analysis of patients with nosocomial pneumonia during mechanical ventilation (so-called ventilator-associated pneumonia)].
    Kobashi Y; Tanabe J; Fujita K; Karino T; Yano T; Nakamura J; Okimoto N; Matsushima T; Soejima R
    Kansenshogaku Zasshi; 1998 Sep; 72(9):897-904. PubMed ID: 9796188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
    Korten V; Söyletir G; Yalçın AN; Oğünç D; Dokuzoğuz B; Esener H; Ulusoy S; Tünger A; Aygen B; Sümerkan B; Arman D; Dizbay M; Akova M; Hasçelik G; Eraksoy H; Başaran S; Köksal I; Bayramoğlu G; Akalın H; Sınırtaş M
    Mikrobiyol Bul; 2011 Apr; 45(2):197-209. PubMed ID: 21644063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.